Stem Cells

Latest Headlines

Latest Headlines

Riken's new president vows more partnerships to fix scandal-hit institution

The new president of Japan's Riken research institute vowed to enter into partnerships with more businesses as part of his plan for reform of the institution hit by a scandal over its stem cell research.

China puts stem-cell clinical trial regulation in play with draft for comment

China health authorities have proposed some new regulations for conducting stem-cell clinical trials in the country, one requiring that a 30-year archive of the clinical records of stem-cell donors and patients be maintained.

Stem cell advance may assist new therapies for anemia, leukemia

Scientists at the Scripps Research Institute say they've identified an enzyme necessary for maintaining the stability of hematopoietic stem cells.

Japan stem cell researchers aim at muscular dystrophy

Researchers in Japan said they have been able to stop the deterioration associated with muscular dystrophy by creating stem cells and implanting them in a mouse.

UC Berkeley researchers put their hearts into latest organ-on-a-chip project

A group of bioengineers at UC Berkeley has been hard at work hatching a new "heart-on-a-chip" technology that aims to offer researchers a better, less expensive way to develop new drugs.

Glioblastoma project IDs a new approach to brain cancer and understanding EGFR

Investigators say that they've identified a pathway that can be used to target brain tumor stem cells, adding to potential therapeutic strategies for the aggressive disease glioblastoma.

Stanford scientists use modified RNA to rejuvenate aging cells

Scientists say that they have developed a method to use modified messenger RNA to lengthen telomeres, opening a pathway to countering the effects of aging in cells--a process that might apply to a range of diseases from DMD to diabetes and heart disease.

Michigan investigators finger ATDC gene for aggressive pancreatic cancer

Pancreatic cancer has long loomed as one of the most aggressive killers, typically leaving patients with a poor prognosis and specialists with few options for effective treatment. But now a team at the University of Michigan in Ann Arbor says they have new reason to believe that a particular gene is responsible for the fast-spreading cancer--offering a clear target for drug developers.

Johns Hopkins stem cell team tests out CRISPR tech, with encouraging results

CRISPR technology's potential for gene editing has helped inspire the launch of a trio of closely watched biotech startups with their sights set on some cutting-edge approaches to new therapeutics. And now a team at Johns Hopkins has done some experiments to demonstrate its promise in engineering human stem cell therapies.

Stem cell researchers claim Harvard, Brigham mishandled probe

Two prominent researchers whose work on stem cells has come under review have fired back at Harvard Medical School and Brigham & Women's Hospital in a lawsuit, blaming a coauthor for the problems that triggered one paper to be retracted and another questioned while claiming that the university mishandled its investigation into their efforts.